Abnormal expression of WTAP is discovered in multiple diseases, including cancer or diabetes, to address dysfunctional m6A modification in specific genes (Chen et al., 2019; Huang et al., 2022; Li et al., 2022b; Yu et al., 2021). This evidence concerns the gene WTAP and cancer.